Janssen Alzheimer Immunotherapy;The Regents of the University of California
发明人:
申请号：
EP18165937.6
公开号：
EP3369433A1
申请日:
2005.08.09
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
